Holen Sie sich die Stockscreener-App
1.44
23.08%
0.27
Handel nachbörslich:
1.38
-0.06
-4.17%
Schlusskurs vom Vortag:
$1.17
Offen:
$1.3
24-Stunden-Volumen:
186.97K
Relative Volume:
5.32
Marktkapitalisierung:
$63.84M
Einnahmen:
$118.18M
Nettoeinkommen (Verlust:
$5.99M
KGV:
10.92
EPS:
0.1319
Netto-Cashflow:
$-12.91M
1W Leistung:
+0.00%
1M Leistung:
-17.71%
6M Leistung:
-56.23%
1J Leistung:
+35.85%
1-Tages-Spanne:
$1.29
$1.54
1-Wochen-Bereich:
$1.17
$1.54
52-Wochen-Spanne:
$1.10
$3.72
Intercure Ltd Stock (INCR) Company Profile
Vergleichen Sie INCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| INCR | 1.44 | 63.84M | 118.18M | 5.99M | -12.91M | 0.1319 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-05-18 | Hochstufung | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Aktie (INCR) Neueste Nachrichten
InterCure Ltd. (NASDAQ:INCR) Short Interest Update - MarketBeat
InterCure Ltd. (NASDAQ:INCR) Sees Significant Drop in Short Interest - MarketBeat
InterCure Ltd. (NASDAQ:INCR) Sees Large Decline in Short Interest - MarketBeat
Synbiotic's CAGR Forecast at 80%, ECS Botanics to Expand Footprint in Germany, & More from Intercure - Business of Cannabis -
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive
InterCure Ltd. (NASDAQ:INCR) Sees Significant Increase in Short Interest - MarketBeat
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany - Benzinga
InterCure nears break even in first half of 2024, despite ongoing Israel-Hamas war - Green Market Report
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - GlobeNewswire
InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com
InterCure partners with Cookies to launch cannabis pharmacies in Germany By Investing.com - Investing.com Australia
InterCure partners with Cookies to launch cannabis pharmacies in Germany - Investing.com
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany - Business Wire
InterCure (NASDAQ:INCR) Stock Price Up 0.5% - MarketBeat
Tidal Investments LLC Invests $883,000 in InterCure Ltd. (NASDAQ:INCR) - American Banking and Market News
Cannabis News: Majority of Americans Want Rescheduling or Legalization; European Market Growth Could be Game-Changer; Spotlight on InterCure - Market Research Record
Support for Regulatory Changes Surrounding Cannabis Remains Strong in the US, Companies Like InterCure Could Also Benefit From Growth in Europe - Markets Herald
Mirae Asset Global Investments Co. Ltd. Sells 467,995 Shares of InterCure Ltd. (NASDAQ:INCR) - Defense World
InterCure Ltd. (NASDAQ:INCR) Stake Cut by Mirae Asset Global Investments Co. Ltd. - MarketBeat
InterCure (NASDAQ:INCR) Shares Up 1% - MarketBeat
InterCure (NASDAQ:INCR) Trading 1% Higher - Defense World
InterCure: A Cannabis Industry Leader Still Flying Under The Radar (NASDAQ:INCR) - Seeking Alpha
InterCure (NASDAQ:INCR) Trading Down 1.2% - MarketBeat
The market capitalization of InterCure chaired by Ehud Barak is 1.000 billion shekels - Aurora Israel
IM Cannabis Merger Scrapped, Cel AI Gets a New CEO, & More from Intercure - Business of Cannabis -
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ - Markets Insider
The Daily Hit: May 23, 2024 - Green Market Report
InterCure stock initiated with Overweight rating by Zuanic & Associates By Investing.com - Investing.com
Analyst: Israel's InterCure paving path to big gains - Green Market Report
Leading analyst gives InterCure overweight rating, noting 5x returns potential - FXStreet
Analyst: Israel’s InterCure paving path to big gains - Green Market Report
Intercure Ltd. Files SEC Report, Ensures TransparencyTipRanks.com - TipRanks
InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference - Business Wire
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference - Yahoo Finance
InterCure (NASDAQ:INCR) Shares Down 4.1% - MarketBeat
InterCure (NASDAQ:INCR) Stock Price Down 4.1% - Defense World
InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion - Benzinga
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million - Business Wire
InterCure: Bargain Israel Cannabis Play (NASDAQ:INCR) - Seeking Alpha
Here's What You Missed in Cannabis, Psychedelics This WeekTipRanks.com - TipRanks
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint - Business Wire
InterCure Provides Update Regarding Nir Oz Facility in Israel - Cannabis Business Times
InterCure Provides an Update Regarding Nir Oz Facility - GlobeNewswire
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain - GlobeNewswire
Israeli Cannabis Firms Navigate Challenges Amid Hamas Conflict, Cellular Goods Signs New Joint Venture, & More from SEED Innovations - Business of Cannabis -
InterCure Provides an Update Regarding the Security Situation in Israel - Financial Post
Israeli Cannabis Adjusts to War - Green Market Report
Celadon Announces New £1.2m Supply Deal, Intercure Continues Record Run, & Chill Brands Launches Products in UK - Business of Cannabis -
Finanzdaten der Intercure Ltd-Aktie (INCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):